{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:09:27Z","timestamp":1768518567233,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.ygyno.2006.10.012","type":"journal-article","created":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T21:30:32Z","timestamp":1164835832000},"page":"675-679","source":"Crossref","is-referenced-by-count":10,"title":["Assessment of Her-2\/neu expression in hydatidiform moles for prediction of subsequent gestational trophoblastic neoplasia"],"prefix":"10.1016","volume":"104","author":[{"given":"Joseph","family":"Menczer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Golan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tally","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2006.10.012_bib1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(90)92641-T","article-title":"Gestational trophoblastic tumors following initial diagnosis of partial hydatidiform mole","volume":"335","author":"Bagshawe","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2006.10.012_bib2","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199612053352306","article-title":"Chorionic tumors","volume":"335","author":"Berkowitz","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2006.10.012_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.AOG.0000224697.31138.a1","article-title":"Gestational trophoblastic disease [Clinical Expert Series]","volume":"108","author":"Soper","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0002-9378(95)90575-8","article-title":"Single-agent methotrexate chemotherapy for treatment of nonmetastatic gestational trophoblastic tumors","volume":"172","author":"Lurain","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2006.10.012_bib6","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0029-7844(03)00009-7","article-title":"Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation","volume":"101","author":"Feltmate","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.AOG.0000136099.21216.45","article-title":"Low risk of relapse after achieving undetectable hCG levels in women with complete molar pregnancy","volume":"104","author":"Wolfberg","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0301-2115(03)00274-4","article-title":"How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data","volume":"112","author":"Batorfi","year":"2004","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib9","first-page":"1","article-title":"Hydatidiform mole: diagnosis, management, and long-term follow-up of 347 patients","volume":"45","author":"Curry","year":"1975","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0090-8258(88)90046-7","article-title":"The problem of identification of prognostic factors for persistent trophoblastic disease","volume":"30","author":"Parazzini","year":"1988","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib11","first-page":"402","article-title":"A clinicopathologic study of 153 cases of complete hydatidiform mole (1980\u20131990): histologic grade lacks prognostic significance","volume":"78","author":"Genest","year":"1991","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib12","first-page":"591","article-title":"Predictors of persistent disease in women with complete hydatidiform mole","volume":"41","author":"Ayhan","year":"1996","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2006.10.012_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0002-9378(86)90818-5","article-title":"Radioimmunoassay of free beta-subunit of human chorionic gonadotropin as a prognostic test for persistent trophoblastic disease in molar pregnancy","volume":"155","author":"Khazaeli","year":"1986","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib14","first-page":"212","article-title":"Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles","volume":"74","author":"Berkowitz","year":"1989","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib15","first-page":"495","article-title":"Screening of persistent trophoblastic disease with various serum markers","volume":"19","author":"Mungan","year":"1998","journal-title":"Eur. J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib16","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/gyno.1998.5210","article-title":"Identification of persistent trophoblastic diseases based on a human chorionic gonadotropin regression curve by means of a stepwise piecewise linear regression analysis after the evacuation of uneventful moles","volume":"71","author":"Shigematsu","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/01.AOG.0000174583.51617.25","article-title":"Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy","volume":"106","author":"Wolfberg","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00004347-199601000-00006","article-title":"Trophoblast proliferation rate does not predict progression to persistent gestational trophoblastic disease in complete hydatidiform mole","volume":"15","author":"Jeffers","year":"1996","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1677\/joe.0.1710435","article-title":"Human chorionic gonadotropin (hCG) beta-core fragment is produced by degradation of hCG or free hCG beta in gestational trophoblastic tumors: a possible marker for early detection of persistent postmolar gestational trophoblastic disease","volume":"171","author":"Okamoto","year":"2001","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/gyno.1993.1114","article-title":"CA-125: a marker for persistent gestational trophoblastic disease?","volume":"49","author":"Koonings","year":"1993","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib21","first-page":"495","article-title":"Screening of persistent trophoblastic disease with various serum markers","volume":"19","author":"Mungan","year":"1998","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/gyno.2000.5823","article-title":"Measurement of CA-125 in trophoblastic disease","volume":"78","author":"Kohorn","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1053\/ob.1996.v175.a74413","article-title":"Major basic protein as a marker of malignant potential in trophoblastic neoplasia","volume":"175","author":"Gurian","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib24","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0029-7844(03)00687-2","article-title":"Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation","volume":"102","author":"Petignat","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0002-9378(99)70208-5","article-title":"Telomerase activity in complete hydatidiform mole","volume":"180","author":"Bae","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/gyno.2000.6090","article-title":"Serum levels of macrophage colony stimulating factor in trophoblastic disease","volume":"80","author":"Kohorn","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/172460080602100107","article-title":"Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease","volume":"21","author":"Duc","year":"2006","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.ygyno.2006.10.012_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ygyno.2005.12.045","article-title":"Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib29","first-page":"1147","article-title":"The c-erbB-related oncoproteins in normal placenta and in gestational trophoblastic diseases (in vitro study)","volume":"142","author":"Fulop","year":"2001","journal-title":"Orv. Hetil."},{"key":"10.1016\/j.ygyno.2006.10.012_bib30","first-page":"1069","article-title":"Diagnostic aspects of hydatidiform mole with persistence of polymorphic trophoblastic hyperplasia","volume":"23","author":"Makovitzky","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2006.10.012_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9378(72)90536-4","article-title":"Malignant trophoblastic disorders. Epidemiologic aspects and relationship to hydatidiform mole","volume":"112","author":"Matalon","year":"1972","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00006250-198003000-00015","article-title":"Prospective follow-up of patients with hydatidiform mole","volume":"55","author":"Menczer","year":"1980","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib33","first-page":"75","article-title":"Partial moles: a clinicopathologic study of 25 cases","volume":"59","author":"Czernobilsky","year":"1982","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0301-2115(96)02604-8","article-title":"Gestational trophoblastic disease following the evacuation of partial hydatidiform mole: a review of 66 cases","volume":"71","author":"Zalel","year":"1997","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1006\/gyno.1999.5419","article-title":"Metastatic trophoblastic disease following partial hydatidiform mole: case report and literature review","volume":"74","author":"Menczer","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.10.012_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ygyno.2005.12.048","article-title":"Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806008110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806008110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T16:38:20Z","timestamp":1555951100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825806008110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0090825806008110"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2006.10.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}